Free Trial

Maxim Group's Rating of Nexalin Technology on 10/9/2024

On October 9, 2024, Maxim Group updated its outlook on Nexalin Technology (NASDAQ:NXL) with the action "Initiated Coverage", setting a "Buy" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Maxim Group

DateCompanyAction
10/7/2025
Gain Therapeutics, Inc. stock logo
GANX
Gain Therapeutics
Boost Price Target
10/3/2025
Perfect Moment Ltd. stock logo
PMNT
Perfect Moment
Initiated Coverage
10/3/2025
Perfect Moment Ltd. stock logo
PMNT
Perfect Moment
Initiated Coverage
10/2/2025
Vyome Holdings, Inc. stock logo
HIND
Vyome
Reiterated Rating
10/2/2025
Novogen Limited stock logo
KZIA
Novogen
Boost Price Target
10/2/2025
5E Advanced Materials, Inc. stock logo
FEAM
5E Advanced Materials
Set Price Target
More Ratings From Maxim Group